Artículos de revistas
Guidelines On The Diagnosis And Treatment For Acute Promyelocytic Leukemia: Associação Brasileira De Hematologia, Hemoterapia E Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013
Registro en:
Revista Brasileira De Hematologia E Hemoterapia. Sociedade Brasileira De Hematologia E Hemoterapia, v. 36, n. 1, p. 71 - 92, 2014.
15168484
10.5581/1516-8484.20140018
2-s2.0-84897786053
Autor
Pagnano K.B.B.
Rego E.M.
Rohr S.
Chauffaille M.L.
Jacomo R.H.
Bittencourt R.
Firmato A.B.
Fagundes E.M.
Melo R.A.M.
Bernardo W.
Institución
Resumen
[No abstract available] 36 1 71 92 Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, , IARC: Lyon Rohr, S.S., Pelloso, L.A., Borgo, A., de Nadai, L.C., Yamamoto, M., Rego, E.M., Chauffaille, M.L., Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: Two additional cases with clinical and laboratorial peculiar presentations (2012) Med Oncol, 29 (4), pp. 2345-2347 De Lourdes, C.M., Borri, D., Proto-Siqueira, R., Moreira, E.S., Alberto, F.L., Acute promyelocytic leukemia with t(15;17): Frequency of additional clonal chromosome abnormalities and FLT3 (2008) Leuk Lymphoma, 49 (12), pp. 2387-2389 Gupta, S.K., Sazawal, S., Mahapatra, M., Saxena, R., Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia (2010) Eur J Clin Invest, 40 (10), pp. 960-962 Dimov, N.D., Medeiros, L.J., Kantarjian, H.M., Cortes, J.E., Chang, K.S., Bueso-Ramos, C.E., Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: The M.D (2010) Cancer, 116 (2), pp. 369-376. , Anderson Cancer Center experience of 349 patients Brockman, S.R., Paternoster, S.F., Ketterling, R.P., Dewald, G.W., New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia (2003) Cancer Genet Cytogenet, 145 (2), pp. 144-151 O'Connor, S.J., Forsyth, P.D., Dalal, S., Evans, P.A., Short, M.A., Shiach, C., The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody (1997) Br J Haematol, 99 (3), pp. 597-604 Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet (2009) Blood, 113 (9), pp. 1875-1891 Tallman, M.S., Altman, J.K., How I treat acute promyelocytic leukemia (2009) Blood, 114 (25), pp. 5126-5135 Chang, H., Kuo, M.C., Shih, L.Y., Dunn, P., Wang, P.N., Wu, J.H., Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia (2012) Eur J Haematol, 88 (4), pp. 321-328 Kim, D.Y., Lee, J.H., Lee, J.H., Kim, S.D., Lim, S.N., Choi, Y., Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia (2011) Leuk Res, 35 (2), pp. 152-158 Yanada, M., Matsushita, T., Asou, N., Kishimoto, Y., Tsuzuki, M., Maeda, Y., Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: Incidence, risk factors, and influence on outcome (2007) Eur J Haematol, 78 (3), pp. 213-219 Dally, N., Hoffman, R., Haddad, N., Sarig, G., Rowe, J.M., Brenner, B., Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients (2005) Thromb Res, 116 (2), pp. 109-114 Higuchi, T., Shimizu, T., Mori, H., Niikura, H., Omine, M., Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia (1997) Hematol Oncol, 15 (4), pp. 209-217 Sanz, M.A., Lo Coco, F., Martín, G., Avvisati, G., Rayón, C., Barbui, T., Definition ofrelapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups (2000) Blood, 96 (4), pp. 1247-1253 Huang, H., Qin, Y., Xu, R., You, X., Teng, R., Yang, L., Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks (2012) Leuk Res, 36 (7), pp. 841-845 Candoni, A., Damiani, D., Michelutti, A., Masolini, P., Michieli, M., Michelutti, T., Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia (2003) Eur J Haematol, 71 (1), pp. 1-8 Sanz, M.A., Montesinos, P., Vellenga, E., Rayón, C., de la Serna, J., Parody, R., Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: Long-term outcome of the LPA99 multicenter study by the PETHEMA Group (2008) Blood, 112 (8), pp. 3130-3134 Kawai, Y., Watanabe, K., Kizaki, M., Murata, M., Kamata, T., Uchida, H., Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia (1994) Am J Hematol, 46 (3), pp. 184-188 Rego, E.M., Kim, H.T., Ruiz-Argüelles, G.J., Undurraga, M.S., Uriarte, M.R., Jacomo, R.H., Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL (2013) Blood, 121 (11), pp. 1935-1943 Drapkin, R.L., Gee, T.S., Dowling, M.D., Arlin, Z., McKenzie, S., Kempin, S., Prophylactic heparin therapy in acute promyelocytic leukemia (1978) Cancer, 41 (6), pp. 2484-2490 Tallman, M.S., Kwaan, H.C., Reassessing the hemostatic disorder associated with acute promyelocytic leukemia (1992) Blood, 79 (3), pp. 543-553 Zhao, W., Wang, X., Guo, W., Qu, B., Wang, H., Shen, Z., Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-transretinoic acid or arsenic trioxide treatment (2000) Chin Med J (Engl), 113 (3), pp. 236-240 Escudier, S.M., Kantarjian, H.M., Estey, E.H., Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid (1996) Leuk Lymphoma, 20 (5-6), pp. 435-439 Goldberg, M.A., Ginsburg, D., Mayer, R.J., Stone, R.M., Maguire, M., Rosenthal, D.S., Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? (1987) Blood, 69 (1), pp. 187-191 Hoyle, C.F., Swirsky, D.M., Freedman, L., Hayhoe, F.G., Beneficial effect of heparin in the management of patients with APL (1988) Br J Haematol, 68 (3), pp. 283-289 Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G., Gemon, M.F., Acute promyelocytic leukemia: Results of treatment with daunorubicin (1973) Blood, 41 (4), pp. 489-496 Lengfelder, E., Hanfstein, B., Haferlach, C., Braess, J., Krug, U., Spiekermann, K., Outcome of elderly patients with acute promyelocytic leukemia: Results of the German Acute Myeloid Leukemia Cooperative Group (2013) Ann Hematol, 92 (1), pp. 41-52 Iland, H., Bradstock, K., Seymour, J., Hertzberg, M., Grigg, A., Taylor, K., Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia (2012) Haematologica, 97 (2), pp. 227-234 Avvisati, G., Lo-Coco, F., Paoloni, F.P., Petti, M.C., Diverio, D., Vignetti, M., AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: Very long-term results and role of maintenance (2011) Blood, 117 (18), pp. 4716-4725 Adès, L., Guerci, A., Raffoux, E., Sanz, M., Chevalier, P., Lapusan, S., Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans-retinoic acid and chemotherapy: The European Group APL experience (2010) Blood, 115 (9), pp. 1690-1696 Pagnano, K.B., de Carvalho, D.G., Lorand-Metze, I., Delamain, M.T., Miranda, E.C., de Souza, C.A., Treatment outcome of acute promyelocytic leukemia with modified aida protocol (2010) Adv Hematol, 2010, p. 672137 Shen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia (2004) Proc Natl Acad Sci U S A, 101 (15), pp. 5328-5335 Wang, H., Chen, X.Y., Wang, B.S., Rong, Z.X., Qi, H., Chen, H.Z., The efficacy and safety of arsenic trioxide with or without alltrans retinoic acid for the treatment of acute promyelocytic leukemia: A meta-analysis (2011) Leuk Res, 35 (9), pp. 1170-1177 Elemam, O., Abdelmoety, D., Acute promyelocytic leukemia, study of predictive factors for Differentiation Syndrome, single center experience (2013) J Egypt Natl Canc Inst, 25 (1), pp. 13-19 Breccia, M., Mazzarella, L., Bagnardi, V., Disalvatore, D., Loglisci, G., Cimino, G., Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols (2012) Blood, 119 (1), pp. 49-54 de Botton, S., Dombret, H., Sanz, M., Miguel, J.S., Caillot, D., Zittoun, R., Incidence, clinical features, and outcome of all transretinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group (1998) Blood, 92 (8), pp. 2712-2718 Su, Y.C., Dunn, P., Shih, L.Y., Kuo, M.C., Chang, H., Wu, J.H., Retinoic acid syndrome in patients following the treatment of acute promyelocytic leukemia with all-trans retinoic acid (2009) Chang Gung Med J, 32 (5), pp. 535-542 Jeddi, R., Ghédira, H., Mnif, S., Gouider, E., Fenaux, P., Meddeb, B., High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia (2010) Leuk Res, 34 (4), pp. 545-547 Montesinos, P., Bergua, J.M., Vellenga, E., Rayón, C., Parody, R., de la Serna, J., León, A., Sanz, M.A., Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: Characteristics, outcome, and prognostic factors (2009) Blood, 113 (4), pp. 775-783 Jeddi, R., Kacem, K., Ben Neji, H., Mnif, S., Gouider, E., Aissaoui, L., Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia (2008) Hematology, 13 (3), pp. 142-146 Montesinos, P., Sanz, M., The differentiation syndrome in patients with acute promyelocytic leukemia: Experience of pethema group and review of the literature (2011) Mediterr J Hematol Infect Dis, 3 (1), pp. e2011059 Sastre, A., Gago, E., Baños, M., Gómez, E., Acute renal failure in the transretinóico syndrome (2007) Nefrologia, 27 (2), pp. 184-190 Vahdat, L., Maslak, P., Miller Jr., W.H., Eardley, A., Heller, G., Scheinberg, D.A., Early mortalidade and the the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low dose-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patient treated with all-trans retinoic acid (1994) Blood, 84 (11), pp. 3843-3849 Wiley, J.S., Firkin, F.C., Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukemia Study Group (1995) Leukemia, 9 (5), pp. 774-778 Sanz, M.A., Montesinos, P., Rayón, C., Holowiecka, A., de la Serna, J., Milone, G., Risk-adapted treatament of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome (2010) Blood, 115 (25), pp. 5137-5146 de la Serna, J., Montesinos, P., Vellenga, E., Rayón, C., Parody, R., León, A., Causes e prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarrubicin (2008) Blood, 111 (7), pp. 3395-3402 Tiamkao, S., Sirijirachai, C., Pseudotumor cerebri caused by all-trans-retinoic acid: A case report (2000) J Med Assoc Thai, 83 (11), pp. 1420-1423 Mahmoud, H.H., Hurwitz, C.A., Roberts, W.M., Santana, V.M., Ribeiro, R.C., Krance, R.A., Tretinoin toxicity in children with acute promyelocytic leukaemia (1993) Lancet, 342 (8884), pp. 1394-1395 Selleri, C., Pane, F., Notaro, R., Catalano, L., Santoro, L.E., Luciano, L., All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri (1996) Br J Haematol, 92 (4), pp. 937-940 Visani, G., Bontempo, G., Manfroi, S., Pazzaglia, A., D'Alessandro, R., Tura, S., All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: A possible disease association (1996) Haematologica, 81 (2), pp. 152-154 Chen, H.Y., Tsai, R.K., Huang, S.M., ATRA-induced pseudotumour cerebri--one case report (1998) Kaohsiung J Med Sci, 14 (1), pp. 58-60 Sano, F., Tsuji, K., Kunika, N., Takeuchi, T., Oyama, K., Hasegawa, S., Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid (1998) Intern Med, 37 (6), pp. 546-549 Naderi, S., Nukala, S., Marruenda, F., Kudarvalli, P., Koduri, P.R., Pseudotumour cerebri in acute promyelocytic leukemia: Improvement despite continued ATRA therapy (1999) Ann Hematol, 78 (7), pp. 333-334 Galm, O., Fabry, U., Osieka, R., Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide (2000) Leukemia, 14 (2), pp. 343-344 Colucciello, M., Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia (2003) Arch Ophthalmol, 121 (7), pp. 1064-1065 Yeh, Y.C., Tang, H.F., Fang, I.M., Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia (2006) Jpn J Ophthalmol, 50 (3), pp. 295-296 Dixon, K.S., Hassoun, A., Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole (2010) J Am Pharm Assoc (2003), 50 (6), pp. 742-744 Machner, B., Neppert, B., Paulsen, M., Hofmann, C., Sander, T., Helmchen, C., Pseudotumor cerebri as a reversible side effect of all-trans retinoic acid treatment in acute promyelocytic leukaemia (2008) Eur J Neurol, 15 (7), pp. e68-e69 Gallipoli, P., Drummond, M.W., Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia (2009) Eur J Haematol, 82 (3), pp. 242-243 Schroeter, T., Lanvers, C., Herding, H., Suttorp, M., Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia (2000) Med Pediatr Oncol, 34 (4), pp. 284-286 Decaudin, D., Adams, D., Naccache, P., Castagna, L., Munck, J.N., Maintained all-trans retinoic acid therapy in a patient with pseudotumour cerebri despite aggravated symptoms (1997) Leuk Lymphoma, 27 (3-4), pp. 373-374 Specchia, G., Lo Coco, F., Vignetti, M., Avvisati, G., Fazi, P., Albano, F., Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto (2001) J Clin Oncol, 19 (20), pp. 4023-4028 Kakimoto, T., Takahashi, Y., Watanabe, H., Matsuzawa, M., Sanada, Y., Primary multiple cerebral invasion in acute promyelocytic leukemia dramatically worsened by all-trans retinoic acid (2010) Leuk Res, 34 (5), pp. e137-e139 de Botton, S., Sanz, M.A., Chevret, S., Dombret, H., Martin, G., Thomas, X., Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (2006) Leukemia, 20 (1), pp. 35-41 Adès, L., Sanz, M.A., Chevret, S., Treatment of newly diagnosed acute promyelocytic leukemia (APL): A comparison of French-Belgian-Swiss and PETHEMA results (2007) Epub, p. 1 Adès, L., Chevret, S., Raffoux, E., de Botton, S., Guerci, A., Pigneux, A., Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group (2006) J Clin Oncol, 24 (36), pp. 5703-5710 Sanz, M.A., Vellenga, E., Rayón, C., Díaz-Mediavilla, J., Rivas, C., Amutio, E., All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia (2004) Blood, 104 (12), pp. 3490-3493 Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group (1999) Blood, 94 (4), pp. 1192-1200 Sanz, M.A., Montesinos, P., Rayón, C., Holowiecka, A., de la Serna, J., Milone, G., Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome (2010) Blood, 115 (25), pp. 5137-5146 Schlenk, R.F., Germing, U., Hartmann, F., Glasmacher, A., Fischer, J.T., Valle, D., Fuentes, F., High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia (2005) Leukemia, 19 (6), pp. 978-983 de Botton, S., Fawaz, A., Chevret, S., Dombret, H., Thomas, X., Sanz, M., Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: A retrospective analysis of the European acute promyelocytic leukemia group (2005) J Clin Oncol, 23 (1), pp. 120-126 Sanz, M.A., Labopin, M., Gorin, N.C., de la Rubia, J., Arcese, W., Meloni, G., Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: A survey of the European Cooperative Group for Blood and Marrow Transplantation (2007) Bone Marrow Transplant, 39 (8), pp. 461-469 Dvorak, C.C., Agarwal, R., Dahl, G.V., Gregory, J.J., Feusner, J.H., Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia (2008) Biol Blood Marrow Transplant, 14 (7), pp. 824-830 Apperley, J., Carreras, E., Gluckman, E., Masszi, T., Hematopoietic Stem Cell Transplantation (2012) The EBMT Handbook Chendamarai, E., Balasubramanian, P., George, B., Viswabandya, A., Abraham, A., Ahmed, R., Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy (2012) Blood, 119 (15), pp. 3413-3419 Polampalli, S., Choughule, A., Prabhash, K., Amare, P., Baisane, C., Kabre, S., Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia (2011) Indian J Cancer, 48 (1), pp. 60-67 Lee, S., Kim, Y.J., Eom, K.S., Min, C.K., Kim, H.J., Cho, S.G., The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: Results of a prospective trial (2006) Haematologica, 91 (5), pp. 671-674 Liu, Y.F., Zhu, Y.M., Shen, S.H., Shen, Z.X., Li, J.M., Chen, S.J., Molecular response in acute promyelocytic leukemia: A direct comparison of regular and real-time RT-PCR (2006) Leukemia, 20 (8), pp. 1393-1399 Santamaría, C., Chillón, M.C., Fernández, C., Martín-Jiménez, P., Balanzategui, A., García, S.R., Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia (2007) Haematologica, 92 (3), pp. 315-322 Raffoux, E., Rousselot, P., Poupon, J., Daniel, M.T., Cassinat, B., Delarue, R., Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia (2003) J Clin Oncol, 21 (12), pp. 2326-2334 Carradice, D., Austin, N., Bayston, K., Ganly, P.S., Successful treatment of acute promyelocytic leukaemia during pregnancy (2002) Clin Lab Haematol, 24 (5), pp. 307-311 Yang, D., Hladnik, L., Treatment of acute promyelocytic leukemia during pregnancy (2009) Pharmacotherapy, 29 (6), pp. 709-724 Watanabe, R., Okamoto, S., Moriki, T., Kizaki, M., Kawai, Y., Ikeda, Y., Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy (1995) Am J Hematol, 48 (3), pp. 210-211 Requena, A., Velasco, J.G., Pinilla, J., Gonzalez-Gonzalez, A., Acute leukemia during pregnancy: Obstetric management and perinatal outcome of two cases (1995) Eur J Obstet Gynecol Reprod Biol, 63 (2), pp. 139-141 Incerpi, M.H., Miller, D.A., Posen, R., Byrne, J.D., All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy (1997) Obstet Gynecol, 89 (5 PART 2), pp. 826-828 Giagounidis, A.A., Beckmann, M.W., Giagounidis, A.S., Aivado, M., Emde, T., Germing, U., Acute promyelocytic leukemia and pregnancy (2000) Eur J Haematol, 64 (4), pp. 267-271 Fadilah, S.A., Hatta, A.Z., Keng, C.S., Jamil, M.A., Singh, S., Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid (2001) Leukemia, 15 (10), pp. 1665-1666 Nakamura, K., Dan, K., Iwakiri, R., Gomi, S., Nomura, T., Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid (1995) Ann Hematol, 71 (5), pp. 263-264 Lipovsky, M.M., Biesma, D.H., Christiaens, G.C., Petersen, E.J., Successful treatment of acute promyelocytic leukaemia with all-trans-retinoic-acid during late pregnancy (1996) Br J Haematol, 94 (4), pp. 699-701 Terada, Y., Shindo, T., Endoh, A., Watanabe, M., Fukaya, T., Yajima, A., Fetal arrhythmia during treatment of pregnancy-associated acute promyelocytic leukemia with all-trans retinoic acid and favorable outcome (1997) Leukemia, 11 (3), pp. 454-455 Takitani, K., Hino, N., Terada, Y., Kurosawa, Y., Koh, M., Inoue, A., Plasma all-trans retinoic acid level in neonates of mothers with acute promyelocytic leukemia (2005) Acta Haematol, 114 (3), pp. 167-169 Culligan, D.J., Merriman, L., Kell, J., The management of acute promyelocytic leucemia presenting during pregnancy (2007) Clin Leukemia, 1, pp. 183-191 Cardonick, E., Iacobucci, A., Use of chemotherapy during human pregnancy (2004) Lancet Oncol, 5 (5), pp. 283-291 Siu, B.L., Alonzo, M.R., Vargo, T.A., Fenrich, A.L., Trasient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans retinoic acid (ATRA) early in the second trimester of pregnancy (2002) Int J Gynecol Cancer, 12 (4), pp. 399-402 Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., All-trans retinoic acid in acute promyelocytic leukemia (1997) N Engl J Med, 337 (15), pp. 1201-1208 Latagliata, R., Avvisati, G., Lo Coco, F., Petti, M.C., Diverio, D., Spadea, A., The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 years (1997) Ann Oncol, 8 (12), pp. 1273-1275 Sanz, M.A., Vellenga, E., Rayón, C., Díaz-Mediavilla, J., Rivas, C., Amutio, E., All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia (2004) Blood, 104 (12), pp. 3490-3493 Ades, L., Chevret, S., de Botton, S., Thomas, X., Dombret, H., Beve, B., Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: The European group experience (2005) Leukemia, 19 (2), pp. 230-233. , European APL Group Latagliata, R., Breccia, M., Fazi, P., Vignetti, M., Di Raimondo, F., Sborgia, M., GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors (2011) Br J Haematol, 154 (5), pp. 564-568 Lengfelder, E., Hanfstein, B., Haferlach, C., Braess, J., Krug, U., Spiekermann, K., Outcome of elderly patients with acute promyelocytic leukemia: Results of the German Acute Myeloid Leukemia Cooperative Group (2013) Ann Hematol, 92 (1), pp. 41-52 Diverio, D., Rossi, V., Avvisati, G., de Santis, S., Pistilli, A., Pane, F., Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/ RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial (1998) Blood, 92 (3), pp. 784-789 Santamaría, C., Chillón, M.C., Fernández, C., Martín-Jiménez, P., Balanzategui, A., García, S.R., Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia (2007) Haematologica, 92 (3), pp. 315-322 Grimwade, D., Jovanovic, J.V., Hills, R.K., Nugent, E.A., Patel, Y., Flora, R., Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy (2009) J Clin Oncol, 27 (22), pp. 3650-3658